Research Article

Irisin Contributes to the Hepatoprotection of Dexmedetomidine during Intestinal Ischemia/Reperfusion

Figure 3

The effect of dexmedetomidine on TNF-α, IL-6, and MPO in liver tissues. Dexmedetomidine treatment decreased the (a) TNF-α, (b) IL-6, and (c) MPO levels after intestinal I/R in different groups. The results were presented as the deviation (; , vs. sham group; ; vs. I/R group; vs. I/R+Dex1 group).
(a)
(b)
(c)